Clinical Trials Logo

Pediatric ALL clinical trials

View clinical trials related to Pediatric ALL.

Filter by:

NCT ID: NCT03562910 Completed - Emergencies Clinical Trials

Mobile-based Social Services Screening and Referral Tool in an Pediatric Emergency Department

Start date: May 13, 2019
Phase: N/A
Study type: Interventional

This study will determine the feasibility and effectiveness of using a mobile-based social services screening and referral tool in an urban pediatric Emergency Department (ED). Families will be offered the option to either download the tool, known as HelpSteps, as a mobile application ("app") on a personal cell phone or to use the app on a provided tablet. After leading the family through a brief social needs screening survey, HelpSteps will recommend local social service agencies based on identified needs and location. Families will then complete a brief survey on the ease of use of the tool as well as receive a follow-up call to ask about usefulness of the tool in solving social problems. The investigators will also ask physicians to fill out a brief survey about the use of the tool in the ED.

NCT ID: NCT03539978 Completed - Pediatric ALL Clinical Trials

Peds SM-THINk: Nursing Interventions to Improve Discharge Outcomes

SM-THINk
Start date: August 30, 2018
Phase:
Study type: Observational

This study focuses on the delivery of discharge education by clinical nurses to improve parent and family self-management in the home environment. This study tests an discharge method (SM-THINk protocol) designed to improve the quality of care for hospitalized pediatric patients at the time of discharge, enhance the child's and family's experience, and decrease length of stay and health care utilization (ED visit or re-admission). The SM-THINk protocol is an enhancement to the standard clinical practice and will be implemented for all subjects on two Children's Hospital of Wisconsin (CHW) nursing units. This enhancement will require additional training of the nurses prior to implementation of the research project. This research determines the effectiveness of the training enhanced discharge method. The training is independent from the research project and will evaluate effectiveness of this training. For the enhanced discharge method, clinical nurses on the study units will be trained to deliver the Self-Management Transition to Home (SM-THINk protocol), which is based on the family self-management discharge preparation previously developed and tested by the study team.

NCT ID: NCT03533049 Completed - Pediatric ALL Clinical Trials

mHealth Family Self-Management

myFAMI
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

This innovative research will address a gap in the literature involving the evaluation of the impact of an individualized family-centered mHealth application to enhance daily post-discharge communication following pediatric transplant. This proposal lays the foundation for future research with myFAMI (self-management intervention) at multiple pediatric transplant centers and builds the science from which to consider post discharge monitoring and decrease cost of care in other pediatric chronic illness populations.

NCT ID: NCT03528954 Completed - Pediatric ALL Clinical Trials

Propofol to Reduce the Incidence of Postanesthetic Emergence Agitation in Pediatric Patients Under General Anesthesia

Start date: May 31, 2018
Phase: N/A
Study type: Interventional

This study aimed to know the effectivity of 0.5 mg/kg propofol in the end of anesthesia to reduce the incidence of postanesthetic emergence agitation in pediatric patients under general inhalation anesthesia

NCT ID: NCT03494998 Recruiting - Pediatric ALL Clinical Trials

Refining and Testing the Diagnostic Accuracy of PAT-POPS

Start date: February 8, 2018
Phase:
Study type: Observational

Increasing attendances by children (aged 0-16 years) at UK emergency departments (EDs) is putting pressure on the National Health Service (NHS). Health professionals make complex judgements on whether children attending EDs can be sent home safely or require admission. The Pennine Acute Hospitals (PAT) Paediatric Observation Priority Score (PAT-POPS) was developed as an ED-specific screening tool for this purpose. A preliminary study showed it to be a potentially effective tool for deciding admission of children from the ED. Therefore, the focus of this study is to refine the original screening tool.

NCT ID: NCT03481881 Recruiting - Pediatric ALL Clinical Trials

Pharmacokinetics of Drugs Administered to Children

Start date: August 14, 2013
Phase:
Study type: Observational

This is a prospective study of children <21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.

NCT ID: NCT03463694 Completed - Pediatric ALL Clinical Trials

Edinburgh and Lothian Virus Intervention Study in Kids

ELVIS Kids
Start date: November 2, 2018
Phase: N/A
Study type: Interventional

ELVIS Kids is a parallel, open label, randomised controlled trial (RCT) of Hypertonic Saline (HS) nose drops (~2.6% NaCl) vs. standard care in children <7 years of age with symptoms of an Upper Respiratory Tract Infection (URTI).

NCT ID: NCT03455140 Completed - Cancer Clinical Trials

A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)

PARC
Start date: August 28, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

PARC is an international phase I/II trial evaluating the safety and activity of pegylated recombinant human arginase (BCT-100) in children and young people with relapsed/refractory leukaemia, neuroblastoma, sarcoma and high grade gliomas (brain cancers). Currently the outcomes for these patients are poor and the therapeutic options are limited with a significant toxicity burden. Therefore new treatments which work in different ways to standard chemotherapy are urgently needed. Research has shown that arginine (a nutrient) is important in the survival of cancer cells. BCT-100 is a drug which can deplete arginine levels and starve cancer cells - a completely new approach. BCT-100 has been tested in adults and shown to be active with almost no side-effects. This trial will test whether this dose of BCT-100 is also safe and active in children with relapsed/refractory leukaemia, neuroblastoma, sarcoma and high grade glioma. The trial will also study how BCT-100 is broken down in the body and look for new biological markers of treatment response. Up to 64 children with relapsed cancers will be recruited over 2 years.

NCT ID: NCT03448991 Completed - Pediatric ALL Clinical Trials

Effect of NPO Time and Type of Food Intake on Preoperative Residual Gastric Content and pH

Start date: August 24, 2018
Phase:
Study type: Observational [Patient Registry]

According to normal physiology, the longer fasting period allows food particles to pass stomach through small intestines to minimize intragastric content. The practice guidelines recommend 2-hour fasting period for clear fluid (including water, pulp-free juice and tea or coffee without milk), 4- hour fasting period for breast milk and 6-hour fasting period for non-human milk and solid food to reduce risks of pulmonary aspiration. As a result of longer fasting period, patients tend to experience preoperative dehydrated states and intraoperative hypotension. Patients' demographic data will be obtained from charts. Parents will be asked for type, volume of fluid/food intake and NPO time. This study will be done at BCH's Gastroenterology Procedure Unit (GPU) theaters to measure actual intragastric volume and pH at the beginning esopagogastroduodenoscopy procedures. We hope to demonstrate the relationship between NPO time and actual intragastric volume which provide sufficient data of NPO time to ensure patient's safety.

NCT ID: NCT03414775 Recruiting - Critical Illness Clinical Trials

Influences of High-fiber, Organic Whole-food Formula on the Gut Microbiome in Critically Ill Children

Start date: February 2, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effects of either Pediasure or Nourish formulas on the gastrointestinal microbiome in critically-ill children. Patients will be randomized to received either Pediasure or Nourish.